Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why Submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research

User menu

  • My alerts

Search

  • Advanced search
Life Science Alliance
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research
  • My alerts
Life Science Alliance

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why Submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Follow lsa Template on Twitter
Research Article
Transparent Process
Open Access

The role of MHC class I recycling and Arf6 in cross-presentation by murine dendritic cells

View ORCID ProfileSebastian Montealegre, Anastasia Abramova, Valerie Manceau, View ORCID ProfileAnne-Floor de Kanter, View ORCID ProfilePeter van Endert  Correspondence email
Sebastian Montealegre
1Institut National de la Santé et de la Recherche Médicale, Unité 1151, Paris, France
2Université Paris Descartes, Faculté de Médecine, Paris, France
3Centre National de la Recherche Scientifique, UMR8253, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sebastian Montealegre
Anastasia Abramova
1Institut National de la Santé et de la Recherche Médicale, Unité 1151, Paris, France
2Université Paris Descartes, Faculté de Médecine, Paris, France
3Centre National de la Recherche Scientifique, UMR8253, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valerie Manceau
1Institut National de la Santé et de la Recherche Médicale, Unité 1151, Paris, France
2Université Paris Descartes, Faculté de Médecine, Paris, France
3Centre National de la Recherche Scientifique, UMR8253, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Floor de Kanter
1Institut National de la Santé et de la Recherche Médicale, Unité 1151, Paris, France
2Université Paris Descartes, Faculté de Médecine, Paris, France
3Centre National de la Recherche Scientifique, UMR8253, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne-Floor de Kanter
Peter van Endert
1Institut National de la Santé et de la Recherche Médicale, Unité 1151, Paris, France
2Université Paris Descartes, Faculté de Médecine, Paris, France
3Centre National de la Recherche Scientifique, UMR8253, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter van Endert
  • For correspondence: peter.van-endert@inserm.fr
Published 18 November 2019. DOI: 10.26508/lsa.201900464
  • Article
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF
Loading

Article Figures & Data

Figures

  • Supplementary Materials
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. Effect of Arf6 knockdown on cell surface MHC class I expression.

    BM-DCs were transduced with lentiviruses carrying shRNA sequences targeting Arf6 (shArf6) or a nontargeting (shNT) control. (A) Arf6 relative gene expression to shNT was measured by qPCR. Data represent mean and SEM of n = 5 independent experiments. (B) Transduced C57BL/6 (Kb) or Balb/c (Ld) BM-DCs were stained with mAb against Kb (B8 and AF6) or Ld (64 and 30), followed by a fluorescently labeled secondary antibody and a Bv421-conjugated antibody against CD11c. The fluorescence was recorded in the CD11c+ cells. Data represent mean and SEM of n ≥ 6 independent experiments. (C) Transduced Balb/c cells were permeabilized and stained with mAbs 64 and 30. Data represent mean and SEM of n = 5 independent experiments. (D) Transduced C57BL/6 BM-DCs were incubated with 5 μg/ml BFA; at each time point, cells were stained with the indicated antibodies and analyzed by flow cytometry. (E) Kb levels at the cell surface of shArf6-transduced BM-DCs during the BFA treatment were plotted as the percentage of Kb levels of shNT-transduced cells. (F) Balb/c BM-DCs were acid-stripped or not and reincubated at 37°C in the presence of 5 μg/ml BFA. Then, acid-treated cells were stained with mAb 64 and untreated cells with mAb 30. (G) The Ld levels at the cell surface of shArf6-transduced BM-DCs during the BFA treatment were plotted as the percentage of Ld levels on shNT-transduced cells. Data represent the means and SEM of n = 3 independent experiments. (H) Transduced C57BL/6 BM-DCs were acid stripped and reincubated at 37°C in the presence or absence of 5 μg/ml BFA before staining with AF6; a representative experiment is shown. (I, H) Data in (H) expressed as a percentage of cell surface values before acid stripping. (J) The Kb levels at the cell surface of acid-stripped shArf6-transduced BM-DCs incubated without BFA are plotted as the percentage of Kb levels of shNT-transduced cells. Data represent the means and SEM of n = 3 independent experiments. Data in (A, B, C, J) were evaluated with a one-sample t test, under the null hypotheses that the column means of the sample are equal to 100%. Data are significantly different if P ≤ 0.05 (*), P ≤ 0.01 (**), or P ≤ 0.001 (***).

  • Figure S1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S1. Detection of unfolded Ld molecules by microscopy and flow cytometry.

    (A) shNT and shArf6-transduced Balb/c BM-DCs were stained for unfolded and folded Ld molecules at the cell surface. (B, C) shNT and shArf6-transduced Balb/c or C57BL/6 BM-DCs were stained for unfolded and folded Ld molecules intracellularly. (D, E) Balb/c BM-DCs were acid stripped and stained for folded and unfolded Ld molecules using mAbs 30 and 64, respectively, for analysis by immunofluorescence microscopy. (D, E, F) Control C57BL/6 BM-DCs were stained using mAbs 64 and 30 as in (D) and (E) and analyzed by confocal microscopy. Nuclei are stained with DAPI (blue). NT, non-targeting shRNA.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. Intracellular localization of Arf6 in the DC 2.4 cell line.

    (A, B, C) Steady state DC 2.4 cells expressing Arf6-mCherry were stained with antibodies against (A) EEA-1, (B) LAMP-1, (C) Rab11. Scale bar: 5 μm. (A, B, C, D) Quantification of (A, B, C). Nuclei are stained with DAPI (grey). Data represent at least 25 cells from n = 3 independent experiments.

  • Figure S2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S2. Nocodazole disturbs the intracellular Arf6 compartment.

    DC2.4 cells transduced with Arf6-mCherry were treated with 5 μg/ml nocodazole for 30 min at 37°C. (A, B, C, D) Cells were fixed, permeabilized, and stained with antibodies against (A), EEA-1 (B), LAMP-1 (C), Rab11 (D), total MHC class I (Exon 8). Nuclei are stained with DAPI (grey). Scale bar: 5 μm.

  • Figure S3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S3. Intracellular localization of Kb after extended internalization.

    (A, B), C57BL/6 BM-DCs were acid stripped followed by staining with mAb B8 (B), C57BL/6 BM-DCs were pulsed with mAb AF6 on ice, washed, and analyzed by confocal microscopy after secondary antibody and Rab11 staining either immediately or after a 2 h incubation at 37°C to allow for Kb internalization. Note that visualization of internalized H-2Kb requires overexposure (two bottom row images). Nuclei are stained with DAPI. Scale bars: 20 μm; magnifications: 5 μm. (blue). NT, nontargeting shRNA.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3. Folded and unfolded MHC-I enter early endosomes independently of Arf6.

    (A, B) Transduced Balb/c BM-DCs were fixed, permeabilized, and stained with a combination of antibodies: EEA-1 (red) and 64 (green, (A)) or 30 (green, (B)). (A, C, D) Cells were preincubated with 64 (after acid stripping) (C) or 30 (D) on ice water 30 min. After washing excess antibodies, cells were incubated for the indicated time points at 37°C, and then treated as in (A). (C, D, E, F) Quantification of (C) and (D). Nuclei are stained with DAPI (blue). Data represent at least 15 cells per condition from two independent experiments. Nuclei are stained with DAPI (blue). Scale bars = 20 μm in upper panels, and 5 μm in lower panels. NT, nontargeting shRNA.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4. Delayed disappearance of unfolded MHC-I in Arf6-depleted cells.

    (A, B) Transduced Balb/c BM-DCs cells were fixed, permeabilized, and stained with antibodies against LAMP1 (red) and 64 (green, (A)) or 30 (green, (B)). (A, C, D) Cells were preincubated with 64 (after acid stripping) (C) or 30 (D) on ice water 30 min, washed, incubated for the indicated duration at 37°C, and treated as in (A). (E) Cells were preincubated with 20 nM ConB, acid-stripped, pulsed with 64 on ice water 30 min, reincubated for 2 h at 37°C with ConB, fixed, and stained with antibodies against LAMP1 (red), EEA-1 (magenta), and a secondary antibody against 64 (green). (E, F) Cells were treated as in (E) but without acid stripping and stained with mAb 30 (green). (E, G) Quantification of (E). (F, H) Quantification of (F). The area (left panel) and mean grey values (center panel) of each cell were quantified as described in material and methods, and the product area × mean grey value was expressed as the integrated density. Data in (E) and (G) are from at least 62 cells from three independent experiments. Data in (F) and (H) are from at least 42 cells from three independent experiments. Data were evaluated with an unpaired nonparametric Mann–Whitney test, P ≤ 0.05 (*), P ≤ 0.01 (**), or P ≤ 0.001 (***). Nuclei are stained with DAPI (blue). Scale bars = 20 μm in upper panels, and 5 μm in lower panels. NT, nontargeting shRNA.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5. Folded MHC-I residing in the ERC are not derived from the cell surface.

    (A, B) Transduced Balb/c BM-DCs cells were fixed, permeabilized, and stained with antibodies against Rab11a (red) and with 64 (green, (A)) or 30 (green, (B)). (A, C, D) Cells were pulsed with 64 (after acid stripping, (C)) or 30 (D) on ice water, incubated for the indicated time points at 37°C, and treated as in (A). Nuclei are stained with DAPI (blue). Data represent at least 27 cells per condition from n ≥ 3 independent experiments. Scale bars = 20 μm in upper panels, and 5 μm in lower panels. NT, nontargeting shRNA.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6. MHC-I colocalizing with Arf6 is not derived from the cell surface.

    (A) DC 2.4 cells expressing Arf6-mCherry were fixed, permeabilized, and stained with the antibody exon 8. Quantification represents 30 cells from three independent experiments. (B, C) DC 2.4 cells expressing Arf6-mCherry were pulsed on ice with AF6, incubated for 20 (B), or 60 min (C), at 37°C to allow for internalization, fixed, permeabilized, and stained for Rab11 and AF6 (secondary antibody only). Nuclei are stained with DAPI (blue). Scale bars 5 = μm.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7. MHC-I recycles through a fast Arf6-independent pathway in BM-DCs.

    (A) C57BL/6 BM-DCs were pulsed with AF6 for 30 min on ice and shifted to 37°C for 30 min in the presence or absence of primaquine to allow for internalization and stained for AF6 using a secondary antibody. (A, B) BM-DCs were treated as in (A) including the internalization step for 30′, acid stripped, reincubated at 37°C in the absence of primaquine to allow for recycling, and finally stained with a secondary antibody for analysis by flow cytometry. (C) Transduced C57BL/6 BM-DCs were pulsed with AF6 as in (A) and then allowed to internalize AF6-bound H-2Kb for 60 min in the presence of primaquine. (B, D) Recycling of H-2Kb was analyzed as in (B), following an internalization step of 60 min. (A, B, C, D) Data represent means and SEM of n = 3 (A, B) and n = 4 (C, D) independent experiments. NT, nontargeting shRNA.

  • Figure S4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S4. Representative recycling assay.

    (A, B), Representative histograms of an individual experiment of cells treated as on Fig 7A and B. (A, B, C), Geometric means of all the time points from panels (A) and (B). (A, B, C, D), Zoom into the geometric means of the recycling stage shown in panels (A), (B), and (C). NT, nontargeting shRNA.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8. Effect of Arf6 depletion on cross-presentation of various antigen forms.

    (A) Transduced C57BL/6 BM-DCs were pulsed with various amounts of SL8 peptide, fixed, and cocultured with OT-I T cells. The next day, the supernatant was recovered and probed for IL-2 by ELISA. (B, C, D, E, F) Cross-presentation to OT-I cells of peptide GS-20 (B), of irradiated yeast cells expressing full length OVA at the cell surface (C), of OVA-anti-OVA IC (D), and of the OVA fusion protein P3UO targeted to CD11c (E), or CD206 (F). (A, B, C, D, E, F) Data represent the means and SD of n = 3 independent experiments (A, B, C, E, F) and n = 4 (D). Data were evaluated with a one-sample t test, under the null hypotheses that the column means of the sample are equal to 100%. Data are significantly different if P ≤ 0.05 (*), P ≤ 0.01 (**), or P ≤ 0.001 (***). NT, nontargeting shRNA.

  • Figure S5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S5. Representative IL-2 secretion after cross-presentation experiments.

    Cells were treated as on Fig 8. (A, B, C, D, E, F), SL8 peptide (B), GS-20 long peptide (C), OVA-yeast (D), IC anti ovalbumin–ovalbumin (E), fusion protein P3UO targeted to CD11c (F), fusion protein P3UO targeted to CD206. Data represent a single experiment with mean and SD of two duplicate samples. NT, nontargeting shRNA.

  • Figure 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 9. Intracellular routing and degradation of ICs and soluble OVA.

    (A) FACS analysis of FcγRI/II cell surface expression in transduced BM-DCs. (B) Arf6-depleted and control BM-DCs were analyzed for IC binding to the surface by pulsing at 4°C with OVA–anti-OVA complexes. Upper panels: focal plane; Lower panels: cumulative z-projection. Scale bar: 20 μm. (C, D) After binding at 4°C, ICs were allowed to internalize at 37°C for 10 or 30 min and cells were stained for EEA-1 (C), and LAMP-1 (D), and a secondary antibody against the OVA antibody. Scale bars, upper panels: 20 μm; lower panels 5 μm. (C, E), Quantification of (C). Data represent at least 15 cells from three independent experiments. Nuclei are stained with DAPI (blue). (F), Transduced BM-DCs were pulsed with soluble OVA-647 on ice and incubated at 37°C for the indicated time points, before recording OVA fluorescence by flow cytometry. Data represent mean and SEM from n = 3 independent experiments. (F, G) As in (F), with the IC formed between an OVA antibody and OVA-647. (H) DC 2.4 cells expressing Arf6-mCherry were fed soluble DQ-OVA at 37°C, and the uptake was followed by live-cell imaging for 1 h. Scale bar: 5 μm. (H, I) As in (H), with IC containing DQ-OVA. Data in (H) and (I) represent n = 2 independent experiments, with 10 cells per condition. NT, nontargeting shRNA.

  • Figure S6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S6. Antigen degradation assays.

    (A, B) ICs between an OVA antibody and 200 μg/ml soluble OVA-647 were formed at an equimolar ratio for 1 h at 4°C. (A, B) Then, (A), soluble OVA-647 or (B), ICs were added to BM-DCs and incubated on ice for 20 min. After extensive washing, fluorescence was analyzed by flow cytometry. (C), DCs were pulsed with DQ-OVA or IC containing DQ-OVA on ice, washed, and analyzed by FACS. NT, nontargeting shRNA.

Supplementary Materials

  • Figures
  • Video 1

    DC 2.4 Arf6-mCherry cells were seeded into IBIDI chambers. After equilibrating the chambers at 37°C and 5% CO2 for 5 min, ICs formed between an anti-OVA antibody and DQ-OVA at 200 μg/ml DQ-OVA were added to the cells, and images were taken every 30 s during 60 min.Download video

  • Video 2

    DC2.4 Arf6-mCherry cells pulsed with IC were monitored for 26 min by live cell imaging.Download video

  • Video 3

    The cells shown in Videos 2 were monitored for an additional 15 min by live cell imaging.Download video

  • Video 4

    One individual cell from Videos 2 is shown.Download video

  • Video 5

    One individual cell from Videos 3 is shown.Download video

  • Video 6

    DC 2.4 Arf6-mCherry cells were seeded into IBIDI chambers. After equilibrating the chambers at 37°C and 5% CO2 for 5 min, soluble DQ-OVA at 200 μg/ml DQ-OVA was added to the cells, and images were taken every 30 s during 60 min. Recording started 20 min after adding OVA.Download video

  • Video 7

    An individual cell from Videos 6 is shown.Download video

PreviousNext
Back to top
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The role of MHC class I recycling and Arf6 in cross-presentation by murine dendritic cells
(Your Name) has sent you a message from Life Science Alliance
(Your Name) thought you would like to see the Life Science Alliance web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
MHC-I endocytic transport in DCs
Sebastian Montealegre, Anastasia Abramova, Valerie Manceau, Anne-Floor de Kanter, Peter van Endert
Life Science Alliance Nov 2019, 2 (6) e201900464; DOI: 10.26508/lsa.201900464

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
MHC-I endocytic transport in DCs
Sebastian Montealegre, Anastasia Abramova, Valerie Manceau, Anne-Floor de Kanter, Peter van Endert
Life Science Alliance Nov 2019, 2 (6) e201900464; DOI: 10.26508/lsa.201900464
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
Issue Cover

In this Issue

Volume 2, No. 6
December 2019
  • Table of Contents
  • Cover (PDF)
  • About the Cover
  • Masthead (PDF)
Advertisement

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgements
    • References
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF

Subjects

  • Immunology
  • Cell Biology

Related Articles

  • No related articles found.

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Aporrectodea caliginosa adaption and acclimatisation
  • Telescoping bimodal latent Dirichlet allocation
  • Neutrophils delay repair in Wallerian degeneration
Show more Research Article

Similar Articles

EMBO Press LogoRockefeller University Press LogoCold Spring Harbor Logo

Content

  • Home
  • Newest Articles
  • Current Issue
  • Archive
  • Subject Collections

For Authors

  • Submit a Manuscript
  • Author Guidelines
  • License, copyright, Fee

Other Services

  • Alerts
  • Twitter
  • RSS Feeds

More Information

  • Editors & Staff
  • Reviewer Guidelines
  • Feedback
  • Licensing and Reuse
  • Privacy Policy

ISSN: 2575-1077
© 2022 Life Science Alliance LLC

Life Science Alliance is registered as a trademark in the U.S. Patent and Trade Mark Office and in the European Union Intellectual Property Office.